(R)-5-(2-(2,5-Difluorophenyl)pyrrolidin-1-yl)-3-nitropyrazolo[1,5-a]pyrimidine, 97%, 5g

1-(tert-Butoxycarbonyl)-4-(p-toluenesulfonyloxy)piperidine>98.0%(HPLC)1g

Fmoc-Lys(Ac)-OH, 97%, 100g

2-(4-Bromophenyl)pyridine>98.0%(GC)(T)1g

3-(Trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine hydrochloride, 98%, 500mg

2-(chloromethyl)isonicotinonitrile hydrochloride, 95.0%, 1g

{1H-pyrrolo[3,2-c]pyridin-7-yl}boronic acid, 98+%, 1g

5-Formyl-2-methoxybenzenesulfonamide, 97.0%, 250mg

2H,3H,5H,6H,7H,8H-pyrido[4,3-c]pyridazin-3-one hydrochloride, 98%, 100mg

(2E)-3-pyrazin-2-ylacrylic acid, 95%, 250mg

[1-({2-[({2-[(dimethylamino)methyl]-1,3-thiazol-4-yl}methyl)sulfanyl]ethyl}amino)-2-nitroethenyl](methyl)amine, 97.0%, 5g

Tetrakis(4-acetylphenyl)methane, 97%, 5g

2,2-Dimethyl-6-(2-oxopropyl)-4H-1,3-dioxin-4-one, 98%, 5g